RSPH news

Invesco S&P 500 Equal Weight Health Care · Healthcare · United States

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
6.9% of RSPH
Quartz · 28 Oct 2026, 12:37 UTC
10 Medicare Advantage insurer ratings for 2027 across 4 categories
7.1% of RSPH
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
5.0% of RSPH
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
5.0% of RSPH
Where to buy RSPH
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Benzinga · 28 Oct 2026, 19:32 UTC
Traders Are Pricing a 7% Swing in Amazon Ahead of Earnings - Amazon.com (NASDAQ:AMZN), Intel (NASDAQ:INTC
3.5% of RSPH
TheStreet · 28 Oct 2026, 19:33 UTC
Breakthrough cancer vaccine catches Wall Street's attention
3.1% of RSPH
Where to buy RSPH
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Seeking Alpha · 28 Oct 2026, 15:55 UTC
Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE) | Seeking Alpha
3.3% of RSPH
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
3.1% of RSPH
24/7 Wall St. · 28 Oct 2026, 12:14 UTC
3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and Gilead
3.3% of RSPH
Yahoo! Finance · 27 Oct 2026, 13:47 UTC
What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
5.1% of RSPH
Investing.com · 28 Oct 2026, 12:23 UTC
Top Managed Health Care Stock Pick From BofA Research By Investing.com
2.7% of RSPH
Benzinga · 28 Oct 2026, 12:00 UTC
Centene Analysts Boost Their Forecasts Following Upbeat Q3 Earnings - Centene (NYSE:CNC)
2.7% of RSPH
Investing.com · 28 Oct 2026, 10:00 UTC
BofA raises Centene stock price target on margin improvements By Investing.com
2.7% of RSPH
Seeking Alpha · 28 Oct 2026, 13:49 UTC
UnitedHealth: Raised Premiums, Market Exits And Member Attrition Deliver Future Resilience | Seeking Alpha
2.3% of RSPH
Investing.com · 28 Oct 2026, 22:07 UTC
Align Q3 2026 slides: aligner growth lifts results, scanner shift continues By Investing.com
1.8% of RSPH
Seeking Alpha · 28 Oct 2026, 21:35 UTC
DaVita Q3 2026 Earnings Preview (NYSE:DVA) | Seeking Alpha
1.8% of RSPH
Investing.com · 28 Oct 2026, 22:31 UTC
Quest Diagnostics director Gary Pfeiffer sells $292,329 in shares By Investing.com
1.7% of RSPH
Seeking Alpha · 28 Oct 2026, 21:02 UTC
Align Technology, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:ALGN) 2026-10-28 | Seeking Alpha
1.8% of RSPH
24/7 Wall St. · 28 Oct 2026, 22:00 UTC
Thermo Fisher Scientific Reaches $704 and a New 52-Week High
1.7% of RSPH
wallstreet:online · 28 Oct 2026, 20:10 UTC
Align Technology Announces CEO Succession Plan
1.8% of RSPH

RSPH news

Where to buy RSPH

Where to buy RSPH